Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This charts like it’s going below the $0.1406 low. Especially with earnings coming only to show cash burn and less cash on hand. Down to 7,700 in Robinhood at $0.22 that I didn’t take out at .34 lol. Guess I’ll hold those hero or zero!
Not much going on here so far
Well hopefully it’s Friday traders selling out and they pick back up next week moving higher.
A perfect Trifecta of cancer stocks is rising. KTRA, CVM, and NWBO, all moving on drug news. In all 3 now, the sky is the limit, and no limit of combo trials coming down the pike. GLTA!
I'm watching. I'm also perfectly fine if I don't get out. The "test buys" only added up to a few thousand shares, so if they decide to pull up a lawn chair and stay put- it's ok.
10 minutes to get you out. Close call at rsi 70.41 overbought and might roll over here.
I'm cheering for your hunch.
Was a good day all around. Only one of my stocks that wasn't green was the Gold Miner and that was totally to be expected.
A good day and close. Good to hear that you’ve lowered your average. This has actually begun to trade as expected of the bottom. Looking at the fact that the one year high is $2.85 which was a meme run I guess. Since the FDA fast track 45 million share day I’ve had a feeling this is going to be walked back north a good little bit. Just a hunch.
Well- that would work. Whenever they get sold, it will make my cost basis for the core position look much better. That'll be helpful down the road. Whenever the patients start getting the drug.
If they hold it around .30 and consolidate you’ll be out in the first hour of the next good day whether it’s Friday or next week.
Think I'll put in a sell order for all of those small lots at $.35. If they sell, fine, it will be a nice profit. If not- no worries. Leaving the core position alone.
Yes I’m up over 40% on the .22’s where it’s trading now which is quite the win in these markets and yet hard pressed to just sell on principle when rolling the dice could be very lucrative with this one. Not actually expecting another flash run to $0.84 but knowing it can happen keeps my attention lol.
Some context to RSI it’s necessary to figure out what timeframe the market is using to drive the big sell off. On a one day one minute chart you can see the oscillation of buy/sell tiggers at 30 and 70 but it’s maybe the one month timeframe that would guide an rsi of 70-80 to begin the sell off cooling unless it was trading sky high because of news.
it's always good to have a sketched in exit plan. Funny- a lot of those little "what are the MMs actually doing" buys are now quite green. I considered selling some of them to bring my cost basis down further, but haven't set up any sell order yet.
Started looking at $0.37 but it’s hard to say if the hype keeps it going higher. Right now the RSI (relative strength index) is exactly at 70 and that’s the threshold for overbought which can mean a sell off coming but it looks to be cooling here and maybe setting up for another leg up later or Friday? RSI 80 would likely trigger me to sell and see how far it drops to cool off before getting back in because it feels like traders are trying to get this higher.
Normally I’d just go long on a good prospect like this but you know how that worked for me from $0.98 so I’m just trying to grind $3 & $6k here or there to feel better and beat the boredom just waiting to hopefully break even.
Be great if they hit a nice news item while there’s a lot of interest now. Wishful lol.
Have you a target to take your next profits yet?
Looking for $0.37 next major resistance.
Yes I went in 68k @ $0.217. Trading and chart just looks strong here is my hunch. Really only gained $0.03 a share dancing around because I wasn’t slick enough to get the .20’s at the close Friday and premarket Tuesday.
From a guy on stocktwits that listened in fwiw,,,hopefully they pull a rabbit out of the hat or r/s it is.
“I asked about potential options for increasing shareholder value/Nasdaq compliance. Their response was that they announced Fast Track designation, looking at other potential FDA Designations, and looking to announce REM-001 trial which will be open label so they'd be able to provide regular updates for that trial. They are also trying to arrange partnerships/non-dilutive capital raises. They also stated they're keeping track of the Nasdaq compliance and will eventually have to consider a reverse split as they're getting close to the compliance deadline. Stated that a hard part is capital markets have been difficult and big pharma in general is still holding off on using all the capital they have.”
Normal volume- decent trading. We'll see what tomorrow brings.
Ouch. What happened to the volume
Lol. Reverse split is next
Lol transient comes in four day increments otherwise she’d have to admit inflation was real. I really miss the Greenspan green-speak and barbiturates Bernanke days.
Maybe also the feds will learn to look further ahead than the next 4 days. But I'm not counting on it.
That’s good. It beats the boredom and it’s been a tough market for any style when the bull flips to bear and you’re at the down 20% tipping point between bear correction versus full on bear market. It’s only half way down if it’s going full bear I figure. My roses case is big money funds don’t want to crash and lose a decade of gains and will support things at this level while rotating out of tech and into consumer and bio while waiting until November when Congress flips and takes away biden’s checkbook. Could happen as the economy is not that bad and Feds seem to get it finally with rate hikes and drawing down their balance sheet etc.
I am reviving my short term swing trade skills. It's not my favorite trading method, but IF we go into recession, it's one I need to keep things balanced. I use a parlay type trade so that keeps it interesting, at least.
Yes thanks I’m going to ride the boards until next week.I’m looking at the support and beginning to wonder if the recent 45 million share day on the fast track news actually moved the float into stronger hands building a base? There’s less than 65 million actually in the trade-able float so it’s a possibility but the kind that can get you bagged just as easily in this one over the two year chart.
I’m trying to build a case to get back in make-up losses and possibly catch a nice run that could be coming lol.
Hopefully next week it breaks one way or the other and I can go all in lol.
Still has a high volume this morning. I'd be sitting quietly too- I don't like to buy things going into a long weekend.
Still fence sitting in cash watching it creep up. Still concerned they drop it and close the gap open at the least.
We’ll shockingly I didn’t get burned getting out at .25 and now if I can 1) get in before it goes back up and 2) not get in too high like I have each time before lol.
LOL! Looking through the rose colored glasses then- we could say it's over-performing!
I’ve also been trying to wrap my head around it’s really a $0.02 stock with 650,000,000 outstanding with potential if you consider the 1-10 reverse split in 2019 under Delmar.
There will be a point where ktra investors make money it’s left to be seen to what degree early investors will profit depending on dilution and reverse splits etc. When it succeeds.
DJIA returning to down under 30,000 now. I have had a 29,500 target for the come to Jesus moment when it either bounces off that technical level and doesn’t look back or collapses and we go full bear market with the bottom tbd. We’re one bad day away from it happening.
It's not a fun stock to own. However- as noted before- I'm just here for the drug which is so needed. It would be nice to make some money on it, but I have other stocks which will do a better job of that. At least at some point. Market's down over 500 points PM so I'm not expecting that today will actually be profitable for me. Sigh............
Twits is new to me after I found a couple of long term guys in KTRA with a decent understanding of the history and pros and cons. Normal quiet room until news comes and then it’s a pump and bash zoo for 6 1/2 hours.
Great looking presentation. With my luck I’ll be out when it runs playing around trading it. Just hard to get past their own disclosure of only two known positive events, Mid 2022 a 15 patient enrollment and endpoint data end of 2023. I guess they could find a partner or some other upside development but the $1 requirement and cash burn feels like a drag on it. So wishy-washy lol.
Once again- they do a nice presentation
https://static.seekingalpha.com/uploads/sa_presentations/636/84636/original.pdf
I used to follow stocktwits once in awhile. Not anymore, though.
A lot of stocks develop a nice trading rhythm. KTRA doesn't seem to want to do that.
I made a couple of small buys today- just as I used to to see how it was "actually" trading and surprise- it traded to my bid both times. I take that for a good sign.
Lol you should see the pump and bash on ktra stocktwits. Like Ihub in the heydays. I wish I wasn’t so gun shy which isn’t my norm but this one is tough to figure. The last .84 run and then the dilution announcement ending up at $0.14 was tough. Today’s gap open is always a risk of returning to fill and then 45 mil out of 65 mil trading today but hardly above last fridays $0.2275 high has me cautious.
KTRA does seem to attract some of the less knowledgeable crowd...........
It had a nice over-exuberant run this am which you took good advantage of. For the rest of the day, I think it's traded pretty well. We'll see how it closes.
Took some. I like the chart here. Heavy volume today. GL. $KTRA
Lol Posted by: TrendTrade2016 Date: 06/15/2022 10:12:06 AM
Post #: 1,028 of 1,045
runner here to 34c
ouch...over 40 m volume and it crashed, can you say insiders dumping through a maker, stock will crash in the weeks to come, they have to November to dilute then reverse split the stock, at least one more big offering is coming that will drive it down it into its grave!!!
Think we have some day traders today- not the norm for this stock for sure.
Yeah this morning it traded 80k up to $0.225 at 5:30 am. Funny how that works. Hard one to figure when it traded 30 million the day it hit .84 and today it’s done 37 million and not near the same rise.
I would expect to hear some comment on the news tomorrow. They had to know it was coming and it undoubtedly explains the higher volume and green days of late.
Nothing in stone just watch to see if they say something tomorrow from the presentation and jump in if traders run it. Otherwise just see if it gets in the teens again and buy it all back lol.
Nice trade for you this morning. Have you a re-entry point in mind?
dumping big time....another offering perhaps on the news drop!
Good bye then, and best of luck with your next venture.
they are dumping stock here to raise cash!!!no revenue....at least 500 bios are going BK, or R/S....all out on this dump!!!
Not necessarily but it sounds good to scare people so there that.
Followers
|
59
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1415
|
Created
|
01/25/13
|
Type
|
Free
|
Moderators |
https://www.kintara.com/
Kintara Therapeutics is focused on developing unique anti-cancer compounds, supported by a strong scientific rationale for development in indications with established biomarkers, and where patients are failing, or are unable to tolerate, current therapies.
VAL-083 is a "first-in-class" small molecule chemotherapeutic. Its unique structure provides many valuable benefits, including the targeting of DNA for its therapeutic effect and its ability to cross the blood brain barrier, critical for activity against central nervous system (CNS) tumors.
VAL-083 has completed Pre-Clinical, Phase I and II trials for the treatment of bevacizumab-refractory glioblastoma multiforme (GBM) and is currently being studied in two Phase II biomarker-driven clinical trials for unmethylated-MGMT GBM.
We are also pursuing the development of VAL-083 in the treatment of ovarian cancer.
REM-001 has broad utility for the treatment of serious cutaneous oncology indications. REM-001 has been previously studied in four Phase 2 and/or Phase 3 clinical trials in patients with cutaneous metastatic breast cancer (“CMBC”), who had previously received chemotherapy and/or failed radiation therapy.
Zacks Small-Cap Research
https://s27.q4cdn.com/906368049/files/News/2021/Zacks_SCR_Research_10112021_KTRA_Vandermosten.pdf
Based on our DCF model and a 15% discount rate, Kintara Therapeutics is valued at approximately $5.25 per share. Our model applies a 60% probability for VAL-083 in unmethylated GBM, a 50% probability in methylated GBM and a 50% probability of approval and commercialization in REM-001 for CMBC. The model includes contributions from the United States and Europe. Other regions will be included upon further clarity.
Shares Outstanding (mil) 43.2
Current Price (10/8/2021) $0.77
Valuation $5.25.
11/03/21
Thanks to its promising pipeline and $0.88 share price, 5-star analyst Michael King, of
H.C. Wainwright, sees an attractive entry point for investors.
“We are bullish about KTRA shares for the following five reasons
: (1) The GBM AGILE trial tests VAL-083 in
all three subtypes of GBM, allowing for multiple opportunities for VAL-083 to prove its
efficacy against phenotypically distinct types of the disease.
(2) VAL-083 is a bifunctional
alkylating agent that crosses the blood brain barrier and exhibits very favorable pharmacologic
properties relative TMZ; fulfilling the need for systemic availability in the brain.
(3) VAL-083
has an established favorable safety record, both from initial trials and prior clinical use in
multiple indications.
(4) Dire unmet need in GBM may present relatively low bar for approval.
(5) Phase 3 ready REM-001 is an additional bonus which is not factored into our valuation
assumptions and could potentially deliver value to shareholders while providing a backstop
against downside,” King explained.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |